Ticagrelor market to reach $2.75 billion by 2030 at 7.3% CAGR, driven by increasing prevalence of cardiovascular diseases worldwide.
Read More
Tibsovo market to reach $1.7 billion by 2030 at 9.3% CAGR, driven by increasing prevalence of acute myeloid leukemia among aging populations.
Read More
Thyroid cancer drugs market to reach $2.39 billion by 2030 at 12.8% CAGR, driven by increasing incidences of thyroid cancer requiring advanced drug therapies.
Read More
Thrombosis and hemostasis biomarkers market to reach $7.37 billion by 2030 at 7.3% CAGR, driven by growing demand for precise and targeted therapies.
Read More
Thrombophilia market to reach $26.5 billion by 2030 at 7.8% CAGR, driven by increasing prevalence of thrombophilic conditions and growing diagnostic awareness.
Read More
Throat sprays market to reach $1.31 billion by 2030 at 5.4% CAGR, driven by increasing incidences of respiratory infections linked to pollution and seasonal illnesses.
Read More
Throat lozenges market to reach $7.29 billion by 2030 at 6.7% CAGR, driven by increasing prevalence of respiratory diseases causing sore throat and irritation.
Read More
Thin film drug manufacturing market to reach $13.35 billion by 2030 at 8.9% CAGR, driven by increase in the global elderly population requiring patient-friendly drug delivery.
Read More
Therapeutic proteins market to reach $332.37 billion by 2030 at 13.5% CAGR, driven by technological advancements in protein engineering and rising prevalence of chronic diseases.
Read More
Therapeutic nutrients and minerals market to reach $113.35 billion by 2030 at 7.6% CAGR, driven by increasing demand for functional foods offering targeted health benefits.
Read More